High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression

被引:72
作者
Sheridan, I
Pybus, OG
Holmes, EC
Klenerman, P
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England
[2] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
关键词
D O I
10.1128/JVI.78.7.3447-3454.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) persists in the majority of those infected despite host immune responses. Evidence has accrued that selectively fixed mutations in the envelope genes (E1 and E2) are associated with viral persistence, particularly those that occur within the first hypervariable region of E2 (HVR1). However, the individual amino acid residues under selection have not been identified, nor have their selection pressures been measured, despite the importance of this information for understanding disease pathogenesis and for vaccine design. We performed a high-resolution analysis of published gene sequence data from individuals undergoing acute HCV infection, employing two phylogenetic methods to determine site-specific selection pressures. Strikingly, we found a statistically significant association between the number of sites selected and disease outcome, with the fewest selected sites in fulminant HCV cases and the greatest number of selected sites in rapid progressors, reflecting the duration and intensity of the arms race between host and virus. Moreover, sites outside the HVR1 appear to play a major role in viral evolution and pathogenesis, although there was no association between viral persistence and specific mutations in E1 and E2. Our analysis therefore allows fine dissection of immune selection pressures, which may be more diverse than previously thought. Such analyses could play a similarly informative role in studies of other persistent virus infections, such as human immunodeficiency virus.
引用
收藏
页码:3447 / 3454
页数:8
相关论文
共 43 条
[21]  
Maddison D.R., 2000, MACCLADE ANAL PHYLOG
[22]   Evolution of hypervariable region 1 of hepatitis C virus in primary infection [J].
Manzin, A ;
Solforosi, L ;
Petrelli, E ;
Macarri, G ;
Tosone, G ;
Piazza, M ;
Clementi, M .
JOURNAL OF VIROLOGY, 1998, 72 (07) :6271-6276
[23]   Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR [J].
Pöhlmann, S ;
Zhang, J ;
Baribaud, F ;
Chen, ZW ;
Leslie, G ;
Lin, G ;
Granelli-Piperno, A ;
Dom, RW ;
Rice, CM ;
McsKeating, JA .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4070-4080
[24]   Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy [J].
Ray, SC ;
Wang, YM ;
Laeyendecker, O ;
Ticehurst, JR ;
Villano, SA ;
Thomas, DL .
JOURNAL OF VIROLOGY, 1999, 73 (04) :2938-2946
[25]   Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2 [J].
Roccasecca, R ;
Ansuini, H ;
Vitelli, A ;
Meola, A ;
Scarselli, E ;
Acali, S ;
Pezzanera, M ;
Ercole, BB ;
McKeating, J ;
Yagnik, A ;
Lahm, A ;
Tramontano, A ;
Cortese, R ;
Nicosia, A .
JOURNAL OF VIROLOGY, 2003, 77 (03) :1856-1867
[26]   Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration [J].
Ross, HA ;
Rodrigo, AG .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11715-11720
[27]   The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus [J].
Scarselli, E ;
Ansuini, H ;
Cerino, R ;
Roccasecca, RM ;
Acali, S ;
Filocamo, G ;
Traboni, C ;
Nicosia, A ;
Cortese, R ;
Vitelli, A .
EMBO JOURNAL, 2002, 21 (19) :5017-5025
[28]   A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures [J].
Shimizu, YK ;
Igarashi, H ;
Kiyohara, T ;
Cabezon, T ;
Farci, P ;
Purcell, RH ;
Yoshikura, H .
VIROLOGY, 1996, 223 (02) :409-412
[29]   NEUTRALIZING ANTIBODIES AGAINST HEPATITIS-C VIRUS AND THE EMERGENCE OF NEUTRALIZATION ESCAPE MUTANT VIRUSES [J].
SHIMIZU, YK ;
HIJIKATA, M ;
IWAMOTO, A ;
ALTER, HJ ;
PURCELL, RH ;
YOSHIKURA, H .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1494-1500
[30]  
Shirai M, 1999, J IMMUNOL, V162, P568